We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
23.50 | 1.38% | 1,728.50 | 1,727.50 | 1,728.50 | 1,729.50 | 1,695.50 | 1,705.00 | 6,275,082 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.44 | 71.14B |
TIDMGSK
RNS Number : 3201D
GlaxoSmithKline PLC
25 April 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === =================================================================== a) Name Mr B McNamara === ========================= ======================================== b) Position/status CEO, Consumer Healthcare === ========================= ======================================== c) Initial notification/ Initial notification amendment === ========================= ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =================================================================== a) Name GlaxoSmithKline plc === ========================= ======================================== b) LEI 5493000HZTVUYLO1D793 === ========================= ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ========================= ======================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 13 April 2017 on shares held in the Deferred Annual Bonus Plan Post-Tax - matching award. === ========================= ======================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $41.1461 28.716 --------- ---------- === ========================= ======================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ========================= ======================================== e) Date of the transaction 2017-04-25 === ========================= ======================================== f) Place of the New York Stock Exchange (XNYS) transaction === ========================= ========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQELFLDZFFBBQ
(END) Dow Jones Newswires
April 25, 2017 12:24 ET (16:24 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions